Đang chuẩn bị liên kết để tải về tài liệu:
Pioglitazone and breast cancer risk in female patients with type 2 diabetes mellitus: A retrospective cohort analysis

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Whether pioglitazone may affect breast cancer risk in female diabetes patients is not conclusive and has not been investigated in the Asian populations. This study suggests a null association between pioglitazone and breast cancer risk in female patients with type 2 diabetes mellitus. |

TÀI LIỆU LIÊN QUAN

Pioglitazone use and risk of bladder cancer: An in vitro study

báo cáo hóa học: " Effect of pioglitazone treatment on behavioral symptoms in autistic children"

báo cáo hóa học: " Effect of pioglitazone treatment in a patient with secondary multiple sclerosis"

Báo cáo y học: " Pioglitazone is as effective as dexamethasone in a cockroach allergen-induced murine model of asthma"

Adverse drug effects observed with vildagliptin versus pioglitazone or rosiglitazone in the treatment of patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials

Spectrophotometric assay of pioglitazone hydrochloride using permanganate in acidic and basic media

Sự khác biệt giữa pioglitazone và rosiglitazone, quan điểm hiện nay trong điều trị đái tháo đường týp 2

3’Pool-seq: An optimized cost-efficient and scalable method of whole-transcriptome gene expression profiling

Pioglitazone and breast cancer risk in female patients with type 2 diabetes mellitus: A retrospective cohort analysis